James Veltmeyer
Direttore Tecnico/Scientifico/R&S presso THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
Patrimonio netto: 37 000 $ in data 30/06/2024
Profilo
James Veltmeyer is currently the Chairman-Family Medicine at Sharp Grossmont Hospital since 2009.
He is also the Chief Medical Officer at Therapeutic Solutions International, Inc. since 2018.
Additionally, he is a Member at San Diego Critical Care Medical Group, Inc. Previously, Dr. Veltmeyer worked as an Associate at LXN Corp from 1997 to 2000.
In terms of education, Dr. Veltmeyer completed his undergraduate studies at the University of California San Diego and obtained a doctorate degree from Ross University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 31/12/2023 | 37 000 000 ( 0.81% ) | 37 000 $ | 30/06/2024 |
Posizioni attive di James Veltmeyer
| Società | Posizione | Inizio |
|---|---|---|
| THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. | Direttore Tecnico/Scientifico/R&S | 18/06/2018 |
San Diego Critical Care Medical Group, Inc.
 San Diego Critical Care Medical Group, Inc. Medical/Nursing ServicesHealth Services San Diego Critical Care Medical Group, Inc. is an American company that operates as medical experts providing hospitalist care services. The private company is based in La Mesa. | Corporate Officer/Principal | - |
Sharp Grossmont Hospital
 Sharp Grossmont Hospital Hospital/Nursing ManagementHealth Services Sharp Grossmont Hospital operates hospitals. The private company is based in La Mesa. | Corporate Officer/Principal | 01/07/2009 |
Precedenti posizioni note di James Veltmeyer
| Società | Posizione | Fine |
|---|---|---|
LXN Corp
 LXN Corp Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, LXN Corp is a company that develops and commercializes fructosamine monitoring technology for diabetes. The company is based in San Diego, CA. The company was founded by John F. Burd. LXN was acquired by Inverness Medical Technology, Inc. on March 29, 2001 for $18.48 million. | Corporate Officer/Principal | 01/03/2000 |
Formazione di James Veltmeyer
| University of California San Diego | Undergraduate Degree |
| Ross University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
San Diego Critical Care Medical Group, Inc.
San Diego Critical Care Medical Group, Inc. Medical/Nursing ServicesHealth Services San Diego Critical Care Medical Group, Inc. is an American company that operates as medical experts providing hospitalist care services. The private company is based in La Mesa. | Health Services |
Sharp Grossmont Hospital
Sharp Grossmont Hospital Hospital/Nursing ManagementHealth Services Sharp Grossmont Hospital operates hospitals. The private company is based in La Mesa. | Health Services |
LXN Corp
LXN Corp Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, LXN Corp is a company that develops and commercializes fructosamine monitoring technology for diabetes. The company is based in San Diego, CA. The company was founded by John F. Burd. LXN was acquired by Inverness Medical Technology, Inc. on March 29, 2001 for $18.48 million. | Health Technology |
- Borsa valori
- Insiders
- James Veltmeyer
